![]() |
JOURNAL TOOLS |
Opzioni di pubblicazione |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |
Share |


I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
ORIGINAL ARTICLE
Minerva Anestesiologica 2022 January-February;88(1-2):8-15
DOI: 10.23736/S0375-9393.21.15734-7
Copyright © 2021 EDIZIONI MINERVA MEDICA
lingua: Inglese
Effects of dexmedetomidine on glucose-related hormones and lactate in non-diabetic patients under general anesthesia: a randomized controlled trial
Wei ZHOU 1, Jiahua WANG 1, 2, Dawei YANG 1, Shunping TIAN 1, Chao TAN 2, Yang YANG 1, Wei SUI 1, Jianhong SUN 1, Zhuan ZHANG 1 ✉
1 Department of Anesthesiology, The Affiliated Hospital of Yangzhou University, Yangzhou, China; 2 School of Medicine, Yangzhou University, Yangzhou, China
BACKGROUND: The aim of this study was to explore the effects of dexmedetomidine on glucose-related hormones and lactate levels in non-diabetic patients undergoing malignant gastrointestinal tumor radical resection.
METHODS: Groups D
RESULTS: Compared with group C, glucose levels increased in group D
CONCLUSIONS: Dexmedetomidine loading dose 1 µg/kg and maintenance dose 0.25 µg/kg/h produces a stable insulin level and significant postoperative decreases in glucagon, cortisol, epinephrine and norepinephrine secretion with stable maintenance of intraoperative and postoperative blood glucose levels and decreased postoperative lactate levels in non-diabetic patients under general anesthesia.
KEY WORDS: Dexmedetomidine; Glucose; Hormones; Lactates; Insulin